BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33602682)

  • 1. Spatial Analysis and Clinical Significance of HLA Class-I and Class-II Subunit Expression in Non-Small Cell Lung Cancer.
    Datar IJ; Hauc SC; Desai S; Gianino N; Henick B; Liu Y; Syrigos K; Rimm DL; Kavathas P; Ferrone S; Schalper KA
    Clin Cancer Res; 2021 May; 27(10):2837-2847. PubMed ID: 33602682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between KRAS gene mutations and HLA class I antigen downregulation in the metastasis of non-small cell lung cancer.
    He XP; Song FJ; Liu XY; Wang Z; Li XX; Liu FY; Chen G; Jiang WP
    J Int Med Res; 2013 Oct; 41(5):1473-83. PubMed ID: 23975858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer.
    Kikuchi E; Yamazaki K; Torigoe T; Cho Y; Miyamoto M; Oizumi S; Hommura F; Dosaka-Akita H; Nishimura M
    Cancer Sci; 2007 Sep; 98(9):1424-30. PubMed ID: 17645781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of Class I and II HLA alleles in patients with lung cancer according to chemotherapy response and 5-year survival.
    Araz O; Ucar EY; Meral M; Yalcin A; Acemoglu H; Dogan H; Karaman A; Aydin Y; Gorguner M; Akgun M
    Clin Respir J; 2015 Jul; 9(3):297-304. PubMed ID: 24720676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human leukocyte antigen class I and β2-microglobulin in colorectal cancer and its prognostic impact.
    Na HY; Park Y; Nam SK; Lee KS; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
    Cancer Sci; 2021 Jan; 112(1):91-100. PubMed ID: 33159376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor mutational load, CD8
    Hurkmans DP; Kuipers ME; Smit J; van Marion R; Mathijssen RHJ; Postmus PE; Hiemstra PS; Aerts JGJV; von der Thüsen JH; van der Burg SH
    Cancer Immunol Immunother; 2020 May; 69(5):771-777. PubMed ID: 32047958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
    Perea F; Bernal M; Sánchez-Palencia A; Carretero J; Torres C; Bayarri C; Gómez-Morales M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2017 Feb; 140(4):888-899. PubMed ID: 27785783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective HLA Class I Expression and Patterns of Lymphocyte Infiltration in Chordoma Tumors.
    Patel SS; Nota SP; Sabbatino F; Nielsen GP; Deshpande V; Wang X; Ferrone S; Schwab JH
    Clin Orthop Relat Res; 2021 Jun; 479(6):1373-1382. PubMed ID: 33273248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade.
    Shao XM; Huang J; Niknafs N; Balan A; Cherry C; White J; Velculescu VE; Anagnostou V; Karchin R
    Ann Oncol; 2022 Jul; 33(7):728-738. PubMed ID: 35339648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of HLA class I and class II antigen expressions in borderline, invasive and metastatic ovarian cancers.
    Le YS; Kim TE; Kim BK; Park YG; Kim GM; Jee SB; Ryu KS; Kim IK; Kim JW
    Exp Mol Med; 2002 Mar; 34(1):18-26. PubMed ID: 11989974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of HLA class I and II alleles regarding to lymph node and distant metastasis in patients with non-small cell lung cancer.
    Bulut I; Meral M; Kaynar H; Pirim I; Bilici M; Gorguner M
    Lung Cancer; 2009 Nov; 66(2):231-6. PubMed ID: 19246116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma.
    Talebian Yazdi M; van Riet S; van Schadewijk A; Fiocco M; van Hall T; Taube C; Hiemstra PS; van der Burg SH
    Oncotarget; 2016 Jan; 7(3):3477-88. PubMed ID: 26658106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B.
    Baba T; Hanagiri T; Ichiki Y; Kuroda K; Shigematsu Y; Mizukami M; Sugaya M; Takenoyama M; Sugio K; Yasumoto K
    Cancer Sci; 2007 Nov; 98(11):1795-802. PubMed ID: 17725806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.
    del Campo AB; Kyte JA; Carretero J; Zinchencko S; Méndez R; González-Aseguinolaza G; Ruiz-Cabello F; Aamdal S; Gaudernack G; Garrido F; Aptsiauri N
    Int J Cancer; 2014 Jan; 134(1):102-13. PubMed ID: 23784959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?
    Ramnath N; Tan D; Li Q; Hylander BL; Bogner P; Ryes L; Ferrone S
    Cancer Immunol Immunother; 2006 Aug; 55(8):891-9. PubMed ID: 16187081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer.
    Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Baba T; Uramoto H; So T; Yamada S
    Anticancer Res; 2013 May; 33(5):2123-8. PubMed ID: 23645764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition.
    Del Campo AB; Carretero J; Muñoz JA; Zinchenko S; Ruiz-Cabello F; González-Aseguinolaza G; Garrido F; Aptsiauri N
    Cancer Gene Ther; 2014 Aug; 21(8):317-32. PubMed ID: 24971583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional analysis of beta2 microglobulin abnormalities in human lung and breast cancer.
    Chen HL; Gabrilovich D; Virmani A; Ratnani I; Girgis KR; Nadaf-Rahrov S; Fernandez-Viña M; Carbone DP
    Int J Cancer; 1996 Sep; 67(6):756-63. PubMed ID: 8824545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancer.
    Henick BS; Villarroel-Espindola F; Datar I; Sanmamed MF; Yu J; Desai S; Li A; Aguirre-Ducler A; Syrigos K; Rimm DL; Chen L; Herbst RS; Schalper KA
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA alleles and lung cancer in a Turkish population.
    Ozbek N; Birinci A; Karaoglanoglu O; Coban AY; Okumus B; Cakir S; Durupinar B
    Ann Saudi Med; 2004; 24(2):106-11. PubMed ID: 15323271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.